Although MDS is only infrequently associated with BM fibrosis, preclinical studies indicated that TGF-β is activated in MDS stem and progenitor, resulting in the suppression of normal hematopoiesis (62). The gene discussed is TGFB1; the disease is myelodysplastic syndrome.